跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JURNISTA 32 mg prolonged-release tablet - SFDA Drug Approval Details
Approvals
/
SFDA
/
JURNISTA 32 mg prolonged-release tablet
Authorized
NCE
JURNISTA 32 mg prolonged-release tablet
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
5fc00d7254191c5f
Company
Unknown
Type
NCE
Approval Details
Approval Id
5fc00d7254191c5f
Drug Approval Sfda Name
JURNISTA 32 mg prolonged-release tablet
Trade Name
JURNISTA 32 mg prolonged-release tablet
Generic Name
HYDROMORPHONE HYDROCHLORIDE
Register Number
7-626-15
Register Year
2015
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
28
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Controlled
Storage Conditions
do not store above 30°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
7000000631-32-100000073683
Price
453
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
5fc00d7254191c5f
Type
NCE
Back to SFDA Approvals